Tribunal Upholds Penalties for Medicament Under-Valuation

The Tribunal upheld penalties under Rule 173Q(1) and Rule 25 on registered dealers, M/s Pharmaica and M/s Vipul Drugs, for involvement in under-valuation and clandestine clearance of medicaments. Penalties were reduced but maintained based on their knowledge and registration status. M/s Money Pharma, not a registered dealer, had the penalty set aside. Individuals involved in agreements for recovering money were penalized under Rule 27 for their active participation. The Tribunal's decision differentiated liability based on registration status and active involvement in the illegal activities, ultimately affirming penalties for registered dealers and non-registered entities accordingly.

---

---

Issues:
1. Penalty imposition under Rule 25 on traders, dealers, and consignment agents for under-valuation and clandestine clearance of medicaments.
2. Argument regarding awareness and liability of penalty by the appellants.
3. Interpretation of Rule 25 and liability of registered dealers for penalty.

Analysis:
1. The appeals before the Tribunal involved traders, dealers, and consignment agents penalized for under-valuation and clandestine clearance of medicaments supplied to hospitals. Penalties were imposed under Rule 173Q(1) of Central Excise Rules, 1944 and Rule 25 of the Central Excise Rules, 2002. The appellants contested the penalties, claiming lack of awareness and involvement in the illegal activities.

2. The arguments presented by the appellants focused on their lack of knowledge regarding the violations committed by the principal company, M/s Sarvodaya Laboratory. They emphasized being mere intermediaries for recovering dues and not actively participating in the illegal activities. However, the Tribunal scrutinized the agreements and transactions to establish the appellants' awareness and found them liable for penalties under the specified rules.

3. The Tribunal delved into the interpretation of Rule 25, emphasizing that penalties could be imposed on registered dealers, manufacturers, or importers involved in contraventions, irrespective of actual credit availing or passing on. The judgment differentiated between the liability of registered dealers like M/s Pharmaica and M/s Vipul Drugs, and non-registered entities like M/s Money Pharma. Penalties were upheld for registered dealers due to their registration status and knowledge of the transactions.

4. Ultimately, the Tribunal set aside the penalty on M/s Money Pharma for not being a registered dealer. However, penalties under Rule 173Q(1) and Rule 25 were maintained for M/s Pharmaica and M/s Vipul Drugs. The penalties were reduced based on the circumstances of the case. Additionally, penalties under Rule 27 were imposed on individuals involved in the agreements for recovery of money, affirming their knowledge and involvement in the transactions.

This detailed analysis of the judgment highlights the issues, arguments, legal interpretations, and the Tribunal's decision regarding penalties imposed on the appellants for their roles in under-valuation and clandestine clearance activities.

---